You'd be surprised at the information Paulson can share with their clients who are covered by an NDA. In my opinion, submitting the paperwork to the FDA to request the Hold be lifted, is not a material event and therefore doesn't need to be announced. If and when the FDA releases the Hold, then it becomes a material event. I could be wrong, but I'm not expecting Cyrus to announce the submittal for multiple reasons, but primarily because a rejection would negatively impact the stock. With that said, given the recent events, he may be inclined to announce the submittal to help stop the drop in share price.

Quote:

---

The question is does the company announce they have "completed" the response to the FDA's questions or wait to announce the FDA's answer.

---